Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage
Evaluation Of The Efficacy And Safety Of Minimally Invasive Surgery In Patients With Spontaneous Deep Intracerebral Hemorrhage
Huynh Quoc Huy
300 participants
Sep 8, 2025
OBSERVATIONAL
Conditions
Summary
This observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults with spontaneous deep intracerebral hemorrhage. Consecutive patients admitted to People's Hospital 115 and Tam Anh General Hospital will be enrolled within 72 hours of onset. Clinical and imaging data will be collected prospectively, and outcomes including survival and functional status will be assessed through 180 days.
Eligibility
Inclusion Criteria6
- Age 18 to 80 years
- Spontaneous basal ganglia intracerebral hemorrhage confirmed by non-contrast CT scan
- Hematoma volume 30-80 mL (ABC/2 method)
- Time from onset/last known well ≤ 72 hours
- Glasgow Coma Scale (GCS) score 5-14 at admission
- Pre-stroke modified Rankin Scale (mRS) score 0-1
Exclusion Criteria16
- Secondary intracerebral hemorrhage due to trauma, tumor, vascular malformation, aneurysm, or hemorrhagic transformation of ischemic stroke
- Infratentorial hemorrhage (brainstem or cerebellum)
- Primary thalamic hemorrhage
- Extensive intraventricular hemorrhage (>50% of one lateral ventricle)
- NIHSS < 5 at admission
- Bilateral fixed dilated pupils without light reflex
- Decerebrate posture
- Platelet count < 75,000/µL
- INR > 1.4 after correction
- Ongoing anticoagulation that cannot be rapidly reversed
- Indication for long-term anticoagulation within 5 days of onset
- End-stage renal disease
- End-stage liver disease
- Presence of mechanical heart valve
- Any comorbidity with life expectancy < 6 months
- Patient or legal representative unwilling or unable to provide written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07234955